Hemostemix Inc. faces a significant downturn as its stock drops by over 18% in a single trading day.
On the TSX Venture Exchange, Hemostemix Inc. (HEM.V) has experienced a sharp decline, closing down 18.18% at CA$0.04. This drop raises concerns among investors about the company's financial health and future prospects, especially given its recent focus on financing activities.
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$12.30M
52W high
$0.14
52W low
$0.04
1W change
+7.69%
Beta
0.62
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1271.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1271.4% Upside
Current Price
C$0.07
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
137.6%
Annualized
90-Day Vol
112.7%
Annualized
Trend (90d)
+31.1%
Annualized drift
90d Mean
C$0.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.07 | C$0.05 – C$0.12 |
| 60 trading days | C$0.08 | C$0.04 – C$0.15 |
| 90 trading days | C$0.08 | C$0.03 – C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should be cautious with Hemostemix Inc. as the recent price drop reflects underlying challenges, including reliance on private placements for funding without clear operational progress.
Hemostemix Inc. stock drops 18.18% today
With a market cap of just over CA$10 million, Hemostemix's stock performance is particularly sensitive to investor sentiment and funding developments.
Bull case
If Hemostemix can effectively use its recent financing to move forward with its clinical initiatives and secure regulatory approvals, it might regain investor confidence and improve its stock performance.
Bear case
However, ongoing reliance on private placements, a lack of significant operational updates, and skepticism in the market could further lower Hemostemix's stock price and dampen investor sentiment.
Understanding the Drop
Advertisement
The decline in Hemostemix Inc.'s stock can be linked to several factors, mainly its dependence on private placements for funding. With no recent major operational updates, investor confidence may be fading.
Future Outlook
Looking ahead, Hemostemix needs to turn its financing into real results. Investors will be keeping a close eye on any announcements about clinical advancements or regulatory progress that could impact stock performance.
Investor Sentiment
As a small-cap venture company, Hemostemix's stock is particularly vulnerable to market sentiment. The recent drop may deter potential investors, highlighting the need for the company to enhance transparency and operational clarity.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
